KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Travere Therapeutics (TVTX) over the last 13 years, with Q2 2025 value amounting to 0.12.

  • Travere Therapeutics' Debt Ratio changed N/A to 0.12 in Q2 2025 from the same period last year, while for Jun 2025 it was 0.12, marking a year-over-year change of. This contributed to the annual value of 0.12 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Travere Therapeutics reported Debt Ratio of 0.12 as of Q2 2025.
  • In the past 5 years, Travere Therapeutics' Debt Ratio ranged from a high of 0.14 in Q3 2024 and a low of 0.01 during Q1 2023
  • For the 5-year period, Travere Therapeutics' Debt Ratio averaged around 0.05, with its median value being 0.01 (2022).
  • Its Debt Ratio has fluctuated over the past 5 years, first tumbled by 6673.64% in 2021, then soared by 922.83% in 2022.
  • Over the past 5 years, Travere Therapeutics' Debt Ratio (Quarter) stood at 0.01 in 2021, then increased by 9.23% to 0.01 in 2022, then dropped by 9.97% to 0.01 in 2023, then soared by 1133.73% to 0.12 in 2024, then increased by 7.24% to 0.12 in 2025.
  • Its Debt Ratio was 0.12 in Q2 2025, compared to 0.13 in Q1 2025 and 0.12 in Q4 2024.